Clarify Health is the developer of an analytics platform designed to personalize and optimize patient care journeys, delivering actionable insights that enable physicians, health systems, payers, and life sciences organizations to deliver better care today and evolve for a value-based world.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/05/2022 | Series D-2 | $37.29MM | $xx.xx | $145.29B | Aspenwood Ventures, Blackrock, Insight Partners, Kkr, Memorial Hermann Health System, Rivas Capital, Sigmas Group, Softbank, Spark Capital | |
Price per Share
$xx.xx
Shares Outstanding
3,999,953
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
4.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Aspenwood Ventures, Blackrock, Insight Partners, Kkr, Memorial Hermann Health System, Rivas Capital, Sigmas Group, Softbank, Spark Capital
|
||||||
04/05/2022 | Series D-1 | $165.63MM | $xx.xx | $145.29B | Aspenwood Ventures, Blackrock, Insight Partners, Kkr, Memorial Hermann Health System, Rivas Capital, Sigmas Group, Softbank, Spark Capital | |
Price per Share
$xx.xx
Shares Outstanding
17,767,703
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
4.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Aspenwood Ventures, Blackrock, Insight Partners, Kkr, Memorial Hermann Health System, Rivas Capital, Sigmas Group, Softbank, Spark Capital
|
||||||
03/16/2021 | Series C-1 | $40.83MM | $xx.xx | $46.94B | Concord Health Partners, Hwvp, Insight Partners, Kkr, Rivas Capital, Sigmas Group, Spark Capital | |
Price per Share
$xx.xx
Shares Outstanding
14,130,070
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
4.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Concord Health Partners, Hwvp, Insight Partners, Kkr, Rivas Capital, Sigmas Group, Spark Capital
|
||||||
03/16/2021 | Series C-2 | $76.36MM | $xx.xx | $46.94B | Concord Health Partners, Hwvp, Insight Partners, Kkr, Rivas Capital, Sigmas Group, Spark Capital | |
Price per Share
$xx.xx
Shares Outstanding
21,175,388
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
4.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Concord Health Partners, Hwvp, Insight Partners, Kkr, Rivas Capital, Sigmas Group, Spark Capital
|
||||||
09/10/2018 | Series B | $82.28MM | $xx.xx | $17.92B | Kkr | |
Price per Share
$xx.xx
Shares Outstanding
30,286,082
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
4.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Kkr
|
||||||
05/31/2016 | Series A | $5.96MM | $xx.xx | $1.99B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
6,000,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|